Brief report · 30 Jun 2026
Conference abstractPublished 7 Jun 2017
Design of new drugs: Challenges for the rational development of novel ligands with affinity for G-proteincoupled receptors
ESM- Mexican National Polytechnic Institute, Mexico
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
G-protein-coupled receptors (GPCRs) are a heterogeneous group of proteins that form a physiological and pharmacological perspective results fascinating; their large number of functions and locations in vertebrates make them key pharmacological targets for the development of new drugs, emphasizing those that impact over public health problems in our environment. Within this group, we highlight those GPCRs that are regulated by neurotransmitters derived from amino acids: dopamine, noradrenaline and serotonin receptors are important in the epidemiological context of the country where our workgroup resides because they represent an option to treat diseases such as obesity, depression or Parkinson's disease. However, the phylogenetical similarity between them and the complexity to obtain new crystallized models of GPCRs, slow down the development of new drugs. To obtain highly potent or selective molecules, our workgroup uses an algorithm for pharmacological design that includes the use of computational tools that allows us to obtain the molecular homology model of the receptors and explore the amino acids that are important for its activation or inactivation, along with the calculation of basic pharmacological properties, as well as the evaluation of the docking among the designed ligands and receptors, evaluating the affinity between them, just to complete the experimental design with different in vivo and in vitro techniques, all with the aim of reduce the time of investigation and increase the possibility of develop useful drugs. Several examples of the application of this methodology with the attainment of successful results will be presented.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jose R Bahena Herrera”
- BylineArticles whose byline prints “Erik Andrade Jorge”
- BylineArticles whose byline prints “Jose G Trujillo Ferrara”
